Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving imatinib mesylate together with paclitaxel
works in treating older patients with stage IIIB or stage IV non-small cell lung cancer.
Imatinib mesylate may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth. Drugs used in chemotherapy, such as paclitaxel, work in different ways to
stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving imatinib mesylate together with paclitaxel may kill more tumor cells